By Amber Deter A 23andMe IPO is coming soon. The company recently announced a deal that will bring 23andMe stock to market. And investors are interested in what it has to offer.
But is 23andMe a good investment? Here’s what we know…
23andMe IPO: The Business
CEO Anne Wojcicki co-founded 23andMe in 2006. The company originally started with a direct-to-consumer testing kit so people could find potential health risks in their DNA. However, the FDA ruled it needed regulatory approval. As a result, 23andMe started providing ancestry tests.
On its website, 23andMe says people “should be able to access, understand and benefit from the endlessly interesting and …read more
